 MINATO-KU, TOKYO, JapanBUSINESS WIREAculys Pharma, Inc. Aculys, a clinical stage biopharmaceutical company focused on commercializing innovative treatments for neurological conditions, announced the initiation of a phase 3 clinical study in Japan of pitolisanta histamine H3 receptor antagonistinverse agonist in patients with excessive daytime sleepiness EDS associated with obstructive sleep apnea syndrome OSAS. This trial is ...... 